<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>The Regeneration Station &#187; Athersys</title>
	<atom:link href="http://regeneration-station.com/category/athersys/feed/" rel="self" type="application/rss+xml" />
	<link>http://regeneration-station.com</link>
	<description>Stem cells, biomaterials, engineered tissues, and other cell-based technologies.  The guts of the Regenerative Medine industry.</description>
	<lastBuildDate>Thu, 27 Oct 2011 11:43:42 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='regeneration-station.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>The Regeneration Station &#187; Athersys</title>
		<link>http://regeneration-station.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://regeneration-station.com/osd.xml" title="The Regeneration Station" />
	<atom:link rel='hub' href='http://regeneration-station.com/?pushpress=hub'/>
		<item>
		<title>The Developing Embyronic Stem Cell Clinical Landscape</title>
		<link>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/</link>
		<comments>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/#comments</comments>
		<pubDate>Thu, 14 Feb 2008 11:37:07 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[adult stem cell]]></category>
		<category><![CDATA[Advanced Cell Technology]]></category>
		<category><![CDATA[Athersys]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Cytori]]></category>
		<category><![CDATA[Embyonic Stem Cells]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Geron]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Novocell]]></category>
		<category><![CDATA[Osiris]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[spinal cord injury]]></category>
		<category><![CDATA[stem cells]]></category>
		<category><![CDATA[embryonic vs adult stem cell]]></category>
		<category><![CDATA[embyryonic stem cell 2008]]></category>
		<category><![CDATA[evolving clinical landscape]]></category>
		<category><![CDATA[safety issues]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=93</guid>
		<description><![CDATA[ES cell biopsy from blastocyst.  <img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=93&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/es-cell-biopsy.thumbnail.jpg" medium="image">
			<media:title type="html">es-cell-biopsy.jpg</media:title>
		</media:content>
	</item>
		<item>
		<title>Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial</title>
		<link>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/</link>
		<comments>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/#comments</comments>
		<pubDate>Sun, 23 Dec 2007 17:06:45 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[Angiotech]]></category>
		<category><![CDATA[Athersys]]></category>
		<category><![CDATA[Biomaterials]]></category>
		<category><![CDATA[cardiac regeneration]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Joint Ventures]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[cardiac cell therapy]]></category>
		<category><![CDATA[IND]]></category>

		<guid isPermaLink="false">http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/</guid>
		<description><![CDATA[Athersys and their cardiac parter, Angiotech, announced today that they got the ok from the FDA to begin a Phase I clinical study using Athersys&#8217; Multistem adult stem cell product in acute myocardial infarction (MI). This is the second IND approval for Athersys in just over a month (and a welcome Christmas present for the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=43&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>
	</item>
		<item>
		<title>Athersys’ adult allogeneic stem cell IND gets OK from FDA</title>
		<link>http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/</link>
		<comments>http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/#comments</comments>
		<pubDate>Tue, 20 Nov 2007 17:57:24 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[adult stem cell]]></category>
		<category><![CDATA[Athersys]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[MSCs]]></category>
		<category><![CDATA[Osiris]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[stem cells]]></category>
		<category><![CDATA[adult stem cells]]></category>
		<category><![CDATA[business model]]></category>
		<category><![CDATA[stem cells clinical trials]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/</guid>
		<description><![CDATA[On November 15, 2007, Athersys announced in a press release that they had received a letter from the FDA giving the green light to start a Phase I safety study of MultiStem, their adult, allogeneic stem cell product. Athersys will start an open label, dose escalation trial to test their cells after bone marrow transplantation. [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=7&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>
	</item>
	</channel>
</rss>
